Featured Research

from universities, journals, and other organizations

Many stroke patients not getting preventive therapy for blood clots

Date:
February 11, 2011
Source:
Loyola University Health System
Summary:
Patients with strokes, brain tumors and spinal cord injuries are at high risk for life-threatening blood clots, but many do not receive preventive therapy, researchers report.

Patients with strokes, brain tumors and spinal cord injuries are at high risk for life-threatening blood clots, but many do not receive preventive therapy, Loyola University Health System researchers report.

Neurologic and neurosurgical patients are prone to blood clots because they are immobile or because their blood is more likely to coagulate. But physicians often fail to recognize blood clots in such patients. And even when a blood clot is diagnosed, physicians sometimes fail to treat it with blood-thinning medications due to the risk of hemorrhage.

A blood clot is known as a venous thromboembolism (VTE). A VTE can be either a blood clot in the arms or legs, known as deep venous thrombosis (DVT), or a blood clot in the lungs, known as a pulmonary embolism (PE). A DVT can come loose and travel to the lung. Twenty-five percent of patients with DVT die as a result of subsequent pulmonary embolism, and the seven-day mortality from PE is 75 percent.

"In the long run, the benefits in preventing recurrent VTE outweigh the risk of bleeding complications," Dr. Michael J. Scheck and Dr. José Biller wrote in the February 2011 issue of the American Academy of Neurology journal Continuum.

In most neurologic and neurosurgical patients, beginning therapy with heparin blood-thinning medications within 24 to 48 hours "is both safe and effective," Schneck and Biller wrote.

About 75 percent of stroke patients may develop DVT without prophylactic measures, such as blood-thinning medication, walking as early as possible and compression sleeves and stockings. There's a "wealth of evidence" that such prophylactic measures reduce the frequency of DVT, PE and death in hospitalized patients, Schneck and Biller wrote.

"Neurologic and neurosurgical patients represent a high-risk subgroup because of underlying disease and immobility," Schneck and Biller wrote. "Aggressive intervention for prevention and treatment of DVT is imperative."

Schneck is medical director of Loyola's Neurosciences Intensive Care Unit and vice chair of Research and Faculty Development in the Department of Neurology. Biller is chairman of the Department of Neurology at Loyola University Chicago Stritch School of Medicine.


Story Source:

The above story is based on materials provided by Loyola University Health System. Note: Materials may be edited for content and length.


Cite This Page:

Loyola University Health System. "Many stroke patients not getting preventive therapy for blood clots." ScienceDaily. ScienceDaily, 11 February 2011. <www.sciencedaily.com/releases/2011/02/110211095559.htm>.
Loyola University Health System. (2011, February 11). Many stroke patients not getting preventive therapy for blood clots. ScienceDaily. Retrieved September 17, 2014 from www.sciencedaily.com/releases/2011/02/110211095559.htm
Loyola University Health System. "Many stroke patients not getting preventive therapy for blood clots." ScienceDaily. www.sciencedaily.com/releases/2011/02/110211095559.htm (accessed September 17, 2014).

Share This



More Health & Medicine News

Wednesday, September 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) — Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) — A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) — Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) — President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins